Neoadjuvant Therapy and Axillary Lymph Node Status in HER2-Positive Breast Cancer.

Danzinger, Sabine; Pfeifer, Christian; Wimmer, Sophia; Tendl-Schulz, Kristina; Singer, Christian F

Danzinger, Sabine; Pfeifer, Christian; Wimmer, Sophia; Tendl-Schulz, Kristina; Singer, Christian F.

Afiliação

Danzinger S; Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
Pfeifer C; Department of Statistics, University of Innsbruck, Innsbruck, Austria.
Wimmer S; Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.
Tendl-Schulz K; Department of Pathology, Medical University of Vienna, Vienna, Austria.
Singer CF; Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, Austria.

Cancer Invest ; 41(6): 593-600, 2023 Jul.

Article em En | MEDLINE | ID: mdl-37462505

Assuntos

Neoplasias da Mama; Humanos; Feminino; Neoplasias da Mama/tratamento farmacológico; Neoplasias da Mama/metabolismo; Terapia Neoadjuvante/métodos; Linfonodos/patologia; Receptor ErbB-2/metabolismo; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico

Palavras-chave

HER2-positive breast cancer; axillary response; estimating model; neoadjuvant therapy; pathological node stage

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Cancer Invest Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Áustria

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google